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Dear Editor,
A meta-analysis done by Guo1 that was published in Tobacco Induced 
Diseases, reported a pooled odds ratio of 2.20, concluding that active 
smoking is significantly associated with the risk of severe COVID-19. 
Another current meta-analysis reported greater odds of  COVID-19 
progression among smokers compared to never smokers2. Most of the 
studies in these meta-analyses were from China and focused only on 
cigarette smoking1,2. Here, we describe characteristics of tobacco use among 
193 confirmed COVID-19 patients who were interviewed during their 
hospitalization from 15 March to 15 April 2020, in the Imam-Khomeini 
Hospital of Ardabil University of Medical Sciences (ArUMS) in Iran. 
The protocol was approved by the Institutional Review Board of Ardabil 
University of Medical Sciences (Approval ID: IR.ARUMS.REC.1399.044) 
and verbal informed consent was obtained from the patients.
All patients tested positive for SARS-CoV-2 by nasopharyngeal swabs 
using real-time reverse-transcription-polymerase-chain-reaction (rRT-
PCR) assay; they were at least 18 years old and willing to participate in an 
approximately 5-min interview. Interviews were administrated in the first 
two days of hospitalization to collect information regarding demographics, 
COVID-19-associated symptoms, and use of tobacco products including 
waterpipe (WP, hookah), cigarettes, and e-cigarettes. 
As shown in Table 1, 15 (7.8%) and 14 (7.3%) of the patients reported 
current (past-month) WP or cigarette use, respectively. No patients were 
dual WP/cigarette or e-cigarette users. Of the 14 cigarette smokers, 2 had 
cardiovascular disease (CVD), 1 chronic respiratory illness, 1 diabetes, 2 
other conditions (e.g. kidney illness or rheumatoid arthritis), and 4 reported 
having >1 chronic condition. Among 15 WP smokers, 3 reported having 
CVD, 1 other condition, and 2 having >1 chronic condition. The average 
time between the onset of symptoms and hospitalization was approximately 
4 days for WP smokers, 3 days for cigarette smokers, and 5 days for never-
smokers. More than half (n=8) of cigarette smokers and 40% (n=6) of WP 
smokers reported their COVID-19 symptoms as severe compared to 22% 
(n=36) of never-smokers. 
In line with a previous report3, the most common COVID-19 symptoms 
were fever and dry cough, which did not differ significantly between 
smokers (cigarettes or WP) and never-smokers. However, shortness of 
breath was reported more frequently by cigarette smokers compared to 
never-smokers and WP smokers. Body pain was reported more frequently 
among WP smokers compared to cigarette smokers and never-smokers. 
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Table 1. Descriptive characteristics of adult smokers and never-smokers hospitalized with COVID-19 from 15 
March to 15 April 2020 at Imam-Khomeini Hospital of Ardabil University of Medical Sciences, Ardabil, Iran 
(N=193 )
Characteristics Never-smokers a 
(N=164 )
Waterpipe 
smokers b
(N=15 )
Cigarette 
smokers c 
(N=14 )
p Total 
(N=193 )
n (%) /
mean±SD
n (%) /
mean±SD
n (%) /
mean±SD
n (%) /
mean±SD
Age (years) 52.2±14.8 52.5±11.8 58.2±16.5 0.344 52.6±14.8
Gender 
Male 95 (57.9) 15 (100.0) 13 (92.9) 0.001 123 (63.7)
Female 69 (42.1) 0 (0.00) 1 (7.1) 70 (36.3)
Education 
Illiterate 25 (15.2) 2 (13.3) 3 (21.4) 0.697 30 (15.5)
≤High school 111 (67.7) 11 (73.3) 7 (50.0) 129 (66.8)
Academic  28 (17.1) 2 (13.3) 4 (28.6) 34 (17.6)
History of chronic diseases
None 91 (55.5) 9 (60.0) 4 (28.6) 0.482 104 (53.9)
CVD 24 (14.6) 3 (20.0) 2 (14.3) 29 (15.0)
Pulmonary 7 (4.3) 0 (0.0) 1 (7.1) 8 (4.1)
Diabetes 11 (6.7) 0 (0.0) 1 (7.1) 12 (6.2)
Other 13 (7.9) 1 (6.7) 2 (14.3) 16 (8.3)
>1 condition 18 (11.0) 2 (13.3) 4 (28.6) 24 (12.4)
Days between symptoms onset and 
hospitalization
5.0±2.0 4.0±1.3 3.1±1.0 4.8±1.9
Symptoms (yes vs no)
Dry cough 138 (84.1) 11 (73.3) 13 (92.9) 0.353 162 (83.9)
Fever 108 (65.9) 10 (66.7) 11 (78.6) 0.625 129 (66.8)
Body pain 81 (49.4) 12 (80.0) 5 (35.7) 0.038 98 (50.8)
Shortness of breath 90 (54.9) 3 (20.0) 8 (57.1) 0.033 101 (52.3)
How do you define your symptoms
Mild 51 (31.3) 4 (26.7) 1 (7.1) 0.030 56 (29.2)
Moderate 76 (46.6) 5 (33.3) 5 (35.7) 88 (44.8)
Severe  36 (22.1) 6 (40.0) 8 (57.1) 50 (26.0)
Cigarette smoking frequency/month
<10 – – 3 (21.4) – 3 (21.4)
10–20 – – 7 (50.0) 7 (50.0)
>20 – – 4 (28.6) 4 (28.6)
WP smoking pattern 
Daily/weekly – 8 (53.3) – – 8 (53.3)
Monthly – 7 (46.7) – 7 (46.7)
Outcome of diseased
Discharged in <5 days 102 (62.2) 11 (73.3) 9 (64.3) 0.002 122 (63.2)
Transferred to ICU 60 (36.6) 1 (6.7) 5 (35.7) 66 (34.2)
Died 2 (1.2) 3 (20.0) 0 (0.0) 5 (2.6)
CVD: cardiovascular diseases. ICU: intensive care unit. a Never-smokers were defined as individuals who have never used any kind of tobacco product. b Waterpipe smokers were 
those who smoked WP at least once in past 30 days preceding this study. c Cigarette smokers were those who smoked cigarette at least once in past 30 days preceding this study. 
d Approximately 10 days after the interview, outcome of disease was recorded from hospital records. According to hospital protocol, patients stayed for >5 days only if ICU care 
was needed, to keep beds free for new patients.
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Three out of the five deaths occurred among WP smokers with the remaining two deaths among never-
smokers. When interviewed at the beginning of the study, all three WP smokers and 2 never-smokers who 
later died due to COVID-19 infection reported having chronic conditions.
It is suggested that WP smoking be regulated to restrict COVID-19 transmission4,5 and several countries 
accordingly have temporarily shut down WP cafes4,6. Berlin et al.7 highlighted that ‘lockdown may be an 
opportune moment to quit to reduce not only the smoker’s health risk but also that of his/her family members’. 
This recommendation might not be practical, however, in countries like Iran (the epicenter of COVID-19 in 
the Middle East), where WP smoking is culturally rooted, highly prevalent, and frequently occurs at home8,9. As 
social distancing restrictions are relaxed, it is critical to provide guidelines (e.g. best cleaning practices, hygiene 
standards) and increase awareness regarding the risks of sharing WP. Future studies investigating the association 
between smoking and COVID-19 should consider WP smoking as a potential conduit of infection for this new 
disease. These studies could answer critical questions about whether smoking WP in a café environment will 
increase the risk of contracting coronavirus, how café owners must sanitize WP components to reduce the risk 
of virus transmission, and whether sharing the same WP hose in a home environment between family members 
or friends increases the risk of suffering from serious symptoms due to COVID-19 illness.  
The limitations of this study include the self-report of underlying medical conditions, tobacco smoking, and 
the severity of COVID-19-associated symptoms. Despite these limitations, this descriptive study is among the first 
to describe the patterns of WP use among COVID-19 patients. Our findings highlight the need for larger scale 
studies to further investigate the influence of smoking behavior on the severity and the prognosis of COVID-19. 
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